Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  Shanghai Pharmaceuticals Holding Co., Ltd    601607   CNE000000C82

SHANGHAI PHARMACEUTICALS HOLDING CO., LT

(601607)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Shanghai Pharmaceuticals : REPLY SLIP FOR HOLDERS OF H SHARE ATTENDING THE 2019 SECOND H SHARE CLASS MEETING

share with twitter share with LinkedIn share with facebook
share via e-mail
10/31/2019 | 04:52am EDT

上海醫藥集團股份有限公司

Shanghai Pharmaceuticals Holding Co., Ltd.*

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock Code: 02607)

REPLY SLIP FOR HOLDERS OF H SHARE ATTENDING THE

2019 SECOND H SHARE CLASS MEETING

To: Shanghai Pharmaceuticals Holding Co., Ltd. (the "Company")

Name of shareholder and registered address (Note 1):

being registered holder of (Note 2)

H shares.

I/We intend to attend (in person or by proxy) the 2019 Second H Share Class Meeting to be held at Meeting Room 601, 6th Floor of Affiliated Building, Maple International Building Two, 450 Fenglin Road, Xuhui District, Shanghai, PRC on 18 December 2019 and any adjournment thereof immediately following the conclusion of the 2019 First Extraordinary General Meeting and the 2019 Second A Share Class Meeting of the Company and any adjournment thereof.

Signature of shareholder:

Name of shareholder:

Date:2019

Notes:

  1. Please insert full name(s) (in Chinese or in English) and address(es) (as it is recorded in the register of members of the Company) in block letters.
  2. Please insert the number of shares registered under your name(s).
  3. For holders of H shares of the Company, the completed and signed reply slip should be delivered to the H Share Registrar of the Company, Computershare Hong Kong Investor Services Limited, at 17M Floor, Hopewell Centre, 183 Queen's Road East, Wan Chai, Hong Kong on or before 8 December 2019 in person or by mail. In order to attend and vote at the 2019 Second H Share Class Meeting, holders of H Shares of the Company should ensure that all transfer documents, accompanied by the relevant share certificates, are lodged with the Company's H Share registrar, Computershare Hong Kong Investor Services Limited, at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's Road East, Wan Chai, Hong Kong not later than 16:30 on 9 December 2019.
  • For identification purpose only

Disclaimer

Shanghai Pharmaceuticals Holding Co. Ltd. published this content on 31 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 October 2019 09:51:06 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on SHANGHAI PHARMACEUTICALS H
01/22ENZYMATICA PUBL : signs agreement with Keyuan Trade for China
AQ
2019SHANGHAI PHARMACEUTICALS : Grant of share options under the share option scheme
PU
2019SHANGHAI PHARMACEUTICALS : Results of the extraordinary general meeting, a share..
PU
2019SHANGHAI PHARMACEUTICALS : Notification Letter and Change Request Form to Regist..
PU
2019SHANGHAI PHARMACEUTICALS : Reply slip for holders of h share attending the 2019 ..
PU
2019SHANGHAI PHARMACEUTICALS : Form of proxy of holders of h shares for use at the 2..
PU
2019SHANGHAI PHARMACEUTICALS : Proxy form of the independent non-executive director ..
PU
2019SHANGHAI PHARMACEUTICALS : Notice of 2019 second h share class meeting
PU
2019SHANGHAI PHARMACEUTICALS : Reply slip for holders of h share attending the 2019 ..
PU
2019SHANGHAI PHARMACEUTICALS : Proxy form of holders of h shares for use at the 2019..
PU
More news
Financials (CNY)
Sales 2020 203 B
EBIT 2020 6 967 M
Net income 2020 4 374 M
Debt 2020 23 686 M
Yield 2020 2,51%
P/E ratio 2020 12,5x
P/E ratio 2021 11,1x
EV / Sales2020 0,36x
EV / Sales2021 0,30x
Capitalization 49 521 M
Chart SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
Duration : Period :
Shanghai Pharmaceuticals Holding Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI PHARMACEUTICALS H
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 20,36  CNY
Last Close Price 19,75  CNY
Spread / Highest target 33,2%
Spread / Average Target 3,10%
Spread / Lowest Target -33,3%
EPS Revisions
Managers
NameTitle
Da Wei Liu Deputy Chief Executive Officer
Man Cho President & Executive Director
Jun Zhou Chairman
Bo Shen Chief Financial Officer, Executive Director & VP
Keng Xin Member-Supervisory Board
Sector and Competitors